Vera Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 6.21 M | $180.46 M | -1.43% | 9.74% |
| BLACKROCK, INC. | 11/12/2025 | 4.25 M | $123.42 M | 1.96% | 6.66% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 4.03 M | $117.05 M | 17.54% | 6.31% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 3.67 M | $106.55 M | -18.15% | 5.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 3.64 M | $105.81 M | 8.75% | 5.71% |
| VANGUARD GROUP INC | 11/07/2025 | 3.19 M | $92.72 M | 6.32% | 5.00% |
| FMR LLC | 11/13/2025 | 2.84 M | $82.62 M | -2.30% | 4.46% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 2.81 M | $81.60 M | 17.83% | 4.40% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 2.79 M | $81.19 M | 0.00% | 4.38% |
| STATE STREET CORP | 11/14/2025 | 2.33 M | $67.81 M | 15.66% | 3.66% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 1.70 M | $49.40 M | 47.83% | 2.67% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.62 M | $46.94 M | 186.98% | 2.53% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.44 M | $41.82 M | 86.22% | 2.26% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.35 M | $39.23 M | 0.00% | 2.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.32 M | $38.41 M | 2.06% | 2.07% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.27 M | $36.97 M | 100.00% | 1.99% |
| TRI LOCUM PARTNERS LP | 11/14/2025 | 1.19 M | $34.59 M | 188.11% | 1.87% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 760.00 K | $22.09 M | -75.48% | 1.19% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 758.57 K | $22.04 M | 50.32% | 1.19% |
| WOODLINE PARTNERS LP | 11/14/2025 | 737.58 K | $21.43 M | -71.72% | 1.16% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 708.42 K | $20.59 M | -0.84% | 1.11% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 679.99 K | $19.65 M | 82.43% | 1.07% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 633.82 K | $18.42 M | 4.76% | 0.99% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 617.40 K | $17.94 M | 0.00% | 0.97% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 598.45 K | $17.39 M | 173.48% | 0.94% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 563.08 K | $16.36 M | 0.00% | 0.88% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 536.00 K | $15.58 M | 294.12% | 0.84% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 513.69 K | $14.93 M | 100.00% | 0.81% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 507.10 K | $14.74 M | -9.93% | 0.80% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 490.47 K | $14.25 M | 24.40% | 0.77% |
| BRAIDWELL LP | 11/14/2025 | 472.74 K | $13.74 M | 100.00% | 0.74% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 465.81 K | $13.54 M | 4.80% | 0.73% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 461.41 K | $13.41 M | 47.92% | 0.72% |
| NORTHERN TRUST CORP | 11/14/2025 | 461.26 K | $13.40 M | 0.16% | 0.72% |
| CAPRICORN FUND MANAGERS LTD | 10/17/2025 | 450.70 K | $13.10 M | 100.00% | 0.71% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 440.59 K | $12.80 M | 47.37% | 0.69% |
| CANDRIAM S.C.A. | 11/06/2025 | 427.19 K | $12.41 M | 43.86% | 0.67% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 416.38 K | $12.10 M | -2.70% | 0.65% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 360.33 K | $10.47 M | 134.47% | 0.56% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 354.53 K | $10.30 M | 14.49% | 0.56% |
| NUVEEN, LLC | 11/12/2025 | 317.68 K | $9.23 M | 191.54% | 0.50% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 303.33 K | $8.81 M | -44.34% | 0.48% |
| HSBC HOLDINGS PLC | 11/13/2025 | 297.02 K | $8.63 M | 100.00% | 0.47% |
| ALGERT GLOBAL LLC | 11/14/2025 | 293.39 K | $8.53 M | 15.44% | 0.46% |
| MORGAN STANLEY | 11/14/2025 | 274.52 K | $7.98 M | -87.73% | 0.43% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 253.98 K | $7.38 M | 129.73% | 0.40% |
| ALPHABET INC. | 11/07/2025 | 241.26 K | $7.01 M | 0.00% | 0.38% |
| AXA INVESTMENT MANAGERS S.A. | 11/14/2025 | 229.64 K | $6.67 M | 100.00% | 0.36% |
| BARCLAYS PLC | 11/12/2025 | 217.59 K | $6.32 M | 3.18% | 0.34% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 210.47 K | $6.12 M | 5.09% | 0.33% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vera Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 229 institutional investors and hedge funds held shares of Vera Therapeutics, Inc.. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 6.21 M
BlackRock, Inc.: 4.25 M
Kynam Capital Management, LP: 4.03 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.67 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.64 M
VANGUARD GROUP INC: 3.19 M
102.00% of Vera Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 75.04 M shares in the last 24 months. This purchase volume represents approximately $2.26 B in transactions.